ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2591

Lupus-Related Reproductive Health Experiences and Needs of Women of Childbearing Age: A Qualitative Study

Yasmine Shakur1, Charmayne M. Dunlop-Thomas2, S. Sam Lim1 and Subasri Narasimhan1, 1Emory University, Atlanta, GA, 2Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA

Meeting: ACR Convergence 2024

Keywords: Disparities, gender, pregnancy, Sexual Function, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: ARP Interprofessional I: Epidemiology & Methods

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune condition that primarily affects women of childbearing age, with many patients being diagnosed during puberty. Contraception is recommended for women of childbearing age with lupus to prevent unplanned pregnancies, especially since certain medications used to control the disease can lead to fetal defects if taken during pregnancy.  Unplanned pregnancies in lupus patients can result in adverse fetal outcomes and an increased risk of relapse, adversely affecting the patient’s life. Despite existing knowledge, there remains uncertainty regarding the impact of lupus on fertility for patients with lupus. The purpose of this study was to explore the experiences and needs of minority-identified lupus patients around sexual and reproductive health. The secondary objectives were to identify gaps and explore where improvements can be made to inform lupus patients on how to manage their reproductive health and therefore increase patient-provider trust in their reproductive health.

Methods: Ten minority-identifying women of childbearing age with a physician-confirmed diagnosis of SLE took part in a 30-minute in-depth interview from January 2023 to July 2023, online over Zoom. Participants were members of the Georgians Organized Against Lupus cohort (GOAL), a population-based cohort derived from the Georgia lupus registry. Thematic analysis was used in MAXQDA Plus 2022 to identify themes related to reproductive health with diagnosis, pregnancy, partnerships, holistic care, career, relationships with physicians, family, and medication side effects, and improvements. 

Results:  The participants in the study had an average age of 32.1 years and ranged in age from 26 to 44 years old. Importantly, 100% (n=10) of the participants had discussed sexual and reproductive health with a healthcare provider at some point after their lupus diagnosis. Notable themes identified were living with lupus, physician relationships to support sexual and reproductive health, and sexual and reproductive health concerning lupus.

Conclusion: Most participants were aware of reproductive health prioritization and spoke with providers about concerns that they had about reproductive health. SLE patients expressed that their overall quality of life is affected by their lupus diagnosis. They also changed their reproductive health plans based on their diagnosis. Identified gaps include unexplored emotional and psychological impacts, cultural and social determinants that influence family planning decisions among women with SLE, and socioeconomic status.

Supporting image 1


Disclosures: Y. Shakur: None; C. Dunlop-Thomas: None; S. Lim: Accordant, 2, AstraZeneca, 2, Biogen, 5, BMS, 5, Gilead, 5, GSK, 2, Novartis, 5, UCB, 5; S. Narasimhan: None.

To cite this abstract in AMA style:

Shakur Y, Dunlop-Thomas C, Lim S, Narasimhan S. Lupus-Related Reproductive Health Experiences and Needs of Women of Childbearing Age: A Qualitative Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/lupus-related-reproductive-health-experiences-and-needs-of-women-of-childbearing-age-a-qualitative-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-related-reproductive-health-experiences-and-needs-of-women-of-childbearing-age-a-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology